|
Eyebright (Euphrasia officinalis)
|
|
Eyebright/Drug Interactions:- Cytochrome P450 (CYP 450) Metabolized AgentsCytochrome P450 (CYP 450) Metabolized Agents: Theoretically, eyebright may interact with medications that are metabolized by CYP 450. An animal study conducted on rat livers demonstrated inhibition of CYP 450 by the aglycone of aucubin (4). However, this effect has not been evaluated in humans.
- Hypoglycemic Agents, InsulinHypoglycemic Agents, Insulin: Theoretically, eyebright may interact with medications that alter blood glucose levels. In a rat study, eyebright was found to exert no hypoglycemic effects in normal animals, although in rats with chemically induced diabetes, glucose levels were reduced (3).
|
Eyebright/Herb/Supplement Interactions:- Cytochrome P450 (CYP 450) Metabolized Herbs and SupplementsCytochrome P450 (CYP 450) Metabolized Herbs and Supplements: Theoretically, eyebright may interact with agents that are metabolized by CYP 450. An animal study conducted on rat livers demonstrated inhibition of CYP 450 by the aglycone of aucubin (4). However, this effect has not been evaluated in humans.
- Hypoglycemic Herbs/SupplementsHypoglycemic Herbs/Supplements: Theoretically, eyebright may interact with medications that alter blood glucose levels. In a rat study, eyebright was found to exert no hypoglycemic effects in normal animals, although in rats with chemically-induced diabetes, glucose levels were reduced (3).
|
Eyebright/Food Interactions:- Insufficient available evidence.
|
Eyebright/Lab Interactions:- Insufficient available evidence.
|
Copyright © 2011 Natural Standard (www.naturalstandard.com)
|
The information in this monograph is intended for informational purposes only, and is meant to help users better understand health concerns. Information is based on review of scientific research data, historical practice patterns, and clinical experience. This information should not be interpreted as specific medical advice. Users should consult with a qualified healthcare provider for specific questions regarding therapies, diagnosis and/or health conditions, prior to making therapeutic decisions.
| |
